C-Met-IN-19

C-Met-IN-19 (Compound 21j) is a highly potent c-Met inhibitor exhibiting an IC50 of 1.99 nM. It demonstrates cytotoxic activity against multiple cancer cell lines, including A549, HT-29, SGC-7901, and MDA-MB-231. This inhibitor is a valuable research tool for studying c-Met-driven oncogenesis in both in vitro and in vivo experimental models.